Applied Capital’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-37,499
Closed -$206K 40
2024
Q1
$206K Hold
37,499
0.12% 38
2023
Q4
$221K Buy
+37,499
New +$243K 0.12% 39

Other funds holding AONC

Applied Capital's AONC Position: Q2 2024 in Review

Applied Capital sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q2 2024, closing a stake of 37,499 shares — an estimated $206K sold.

Applied Capital first reported a position in AONC in Q4 2023 and held it in 2 quarters. The position peaked at $221K in Q4 2023. 2 funds tracked by Wall St. Rank hold AONC as of Q2 2024.

  • Applied Capital reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Applied Capital sold 37,499 American Oncology Network, Inc. Class A Common Stock shares in Q2 2024, an estimated $206K.
  • Applied Capital first reported a position in American Oncology Network, Inc. Class A Common Stock in Q4 2023 and held it in 2 quarters.
  • Applied Capital's American Oncology Network, Inc. Class A Common Stock position peaked at $221K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q2 2024.

Based on Applied Capital's 13F filing for Q2 2024, filed 18 Oct 2024.